IL1B and skin disorder: Daily intraperitoneal injections of ΔKerOTULIN mice with Anakinra starting from P18 onwards could suppress dermatitis development in the back skin and tail of these mice, confirming an important contribution of IL-1β in the development of skin lesions (Fig. 6d and Supplementary Fig. 6).